Blog

RSS Feed
Posted by Michael Wonder on 08 May 2020

Celltrion’s Remsima SC launches in Netherlands

7 May 2020 - Subcutaneous rheumatoid arthritis treatment Remsima SC launched in the Netherlands, its third European market, Celltrion Healthcare ...

Read more →
Posted by Michael Wonder on 02 Sep 2019

Dutch experience demonstrates effective benchmarking of biosimilar use in health systems

31 August 2019 - As medicines become more numerous and often more expensive, health care professionals seek new ways to understand ...

Read more →
Posted by Michael Wonder on 03 Apr 2019

AbbVie's massive Humira discounts are stifling Netherlands biosimilars

2 April 2019 - Could a drug's price ever be too low? That’s what some market-watchers are asking in the ...

Read more →